Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Cessation

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para A of Part A of Schedule III to the Listing Regulations, we wish to inform that Dr. Rangaswamy Naidu Maripuri (DIN: 00143836) has stepped down from the position of the Independent Director of the Company due to personal reasons with effect from today, i.e., January 25, 2021. Further, please see below requisite disclosure as per Regulation 30 read with Para A of Part A of Schedule III to the Listing Regulations:
25-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated 21st January, 2021 regarding the Date and Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared today i.e. 22nd January, 2021 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/NoticeofBoardMeeting.aspx This is for your information and record.
22-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) Of The Company Under Ind AS For Quarter Ended 31St December, 2020 And Related Matters.

 SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2021 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Thursday, the 28th January, 2021 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for quarter ended 31st December, 2020 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st January, 2021 as per PIT Code of the Company. Trading window will be opened from 01st February, 2021. You are requested to take this notice on your record.
21-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA dtd. 18/01/2021 regarding issued duplicate share certificate(s) in lieu of the loss of original share certificate(s) to the following shareholders(s).
19-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 017170 Name of the Signatory :- SHRENIK SONIDesignation :- Company Secretary and Compliance Officer
13-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended December 31, 2020, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by M/s. KFin Technologies Private Limited, Registrar & Transfer Agent of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Private Limited dated January 04, 2021 are enclosed for your reference. This is for your information and record.
11-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended December 31, 2020

 Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
07-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window

 We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st January, 2021 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending 31st December, 2020, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and record.
31-12-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Clarification

 With reference to Movement in Volume, Suven Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed.
28-12-2020
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Clarification sought from Suven Life Sciences Ltd

 The Exchange has sought clarification from Suven Life Sciences Ltd on December 28, 2020, with reference to Movement in Volume.The reply is awaited.
28-12-2020
Next Page
Close

Let's Open Free Demat Account